Rubén Cabanillas,Marta Diñeiro,Guadalupe A. Cifuentes,David Castillo,Patricia C. Pruneda,Rebeca Álvarez,Noelia Sánchez-Durán,Raquel Capín,Ana Plasencia,Mónica Viejo-Díaz,Noelia García-González,Inés Hernando,José L. Llorente,Alfredo Repáraz-Andrade,Cristina Torreira-Banzas,Jordi Rosell,Nancy Govea,Justo Ramón Gómez-Martínez,Faustino Núñez-Batalla,José A. Garrote,Ángel Mazón-Gutiérrez,María Costales,María Isidoro-García,Belén García-Berrocal,Gonzalo R. Ordóñez,Juan Cadiñanos

Abstract:BackgroundSensorineural hearing loss (SNHL) is the most common sensory impairment. Comprehensive next-generation sequencing (NGS) has become the standard for the etiological diagnosis of early-onset SNHL. However, accurate selection of target genomic regions (gene panel/exome/genome), analytical performance and variant interpretation remain relevant difficulties for its clinical implementation.MethodsWe developed a novel NGS panel with 199 genes associated with non-syndromic and/or syndromic SNHL. We evaluated the analytical sensitivity and specificity of the panel on 1624 known single nucleotide variants (SNVs) and indels on a mixture of genomic DNA from 10 previously characterized lymphoblastoid cell lines, and analyzed 50 Spanish patients with presumed hereditary SNHL not caused by GJB2/GJB6, OTOF nor MT-RNR1 mutations.ResultsThe analytical sensitivity of the test to detect SNVs and indels on the DNA mixture from the cell lines was > 99.5%, with a specificity > 99.9%. The diagnostic yield on the SNHL patients was 42% (21/50): 47.6% (10/21) with autosomal recessive inheritance pattern (BSND, CDH23, MYO15A, STRC [n = 2], USH2A [n = 3], RDX, SLC26A4); 38.1% (8/21) autosomal dominant (ACTG1 [n = 3; 2 de novo], CHD7, GATA3 [de novo], MITF, P2RX2, SOX10), and 14.3% (3/21) X-linked (COL4A5 [de novo], POU3F4, PRPS1). 46.9% of causative variants (15/32) were not in the databases. 28.6% of genetically diagnosed cases (6/21) had previously undetected syndromes (Barakat, Usher type 2A [n = 3] and Waardenburg [n = 2]). 19% of genetic diagnoses (4/21) were attributable to large deletions/duplications (STRC deletion [n = 2]; partial CDH23 duplication; RDX exon 2 deletion).ConclusionsIn the era of precision medicine, obtaining an etiologic diagnosis of SNHL is imperative. Here, we contribute to show that, with the right methodology, NGS can be transferred to the clinical practice, boosting the yield of SNHL genetic diagnosis to 50–60% (including GJB2/GJB6 alterations), improving diagnostic/prognostic accuracy, refining genetic and reproductive counseling and revealing clinically relevant undiagnosed syndromes.

Next-generation sequencing facilitates genetic diagnosis and improves the management of patients with hearing loss in clinical practice

Resolving the genetic heterogeneity of prelingual hearing loss within one family: Performance comparison and application of two targeted next generation sequencing approaches

Audiological and Genetic Studies on Large Families with Non-Syndromic Deafness

Next‐generation Sequencing Identifies Rare Pathogenic and Novel Candidate Variants in a Cohort of Chinese Patients with Syndromic or Nonsyndromic Hearing Loss

Non-Syndromic Hearing Loss and High-Throughput Strategies to Decipher Its Genetic Heterogeneity

Molecular diagnosis of non-syndromic hearing loss patients using a stepwise approach

Targeted Next-Generation Sequencing Successfully Detects Causative Genes in Chinese Patients with Hereditary Hearing Loss.

Implementing next-generation sequencing for diagnosis and management of hereditary hearing impairment: a comprehensive review

Whole Exome Sequencing of Six Chinese Families with Hereditary Non-Syndromic Hearing Loss.

Genetic screening of a Chinese cohort of children with hearing loss using a next-generation sequencing panel

Comprehensive Genetic Profiling of Sensorineural Hearing Loss Using an Integrative Diagnostic Approach

[Application of next generation sequencing in congenital sensorineural deafness]

Molecular diagnose of a large hearing loss population from China by targeted genome sequencing

Whole-exome sequencing to decipher the genetic heterogeneity of hearing loss in a Chinese family with deaf by deaf mating

Genetic testing for sporadic hearing loss using targeted massively parallel sequencing identifies 10 novel mutations.

A Rapid Improved Multiplex Ligation Detection Reaction Method For The Identification Of Gene Mutations In Hereditary Hearing Loss

Proband Whole-Exome Sequencing Identified Genes Responsible for Autosomal Recessive Non-Syndromic Hearing Loss in 33 Chinese Nuclear Families

Comprehensive genomic diagnosis of non-syndromic and syndromic hereditary hearing loss in Spanish patients

Whole‐exome Sequencing Identifies Rare Pathogenic and Candidate Variants in Sporadic Chinese Han Deaf Patients

Comprehensive genetic analysis of variants in hereditary hearing impairment using long-read sequencing